News List

Lupin gets USFDA nod for generic version of Tamiflu capsules


Lupin has received final approval from the US FDA to market the generic version of Hoffman-La Roche Inc’s Tamiflu capsules

By Team ABLE

Lupin Pharma has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Tamiflu capsules, used in treating influenza.
The company has received final approval from the US drug regulator to market oseltamivir phosphate capsules, a generic version of Hoffman-La Roche Inc’s Tamiflu capsules in strengths of 30 mg, 45 mg, and 75 mg, Lupin said in a statement.

Oseltamivir phosphate capsules are indicated for the treatment of influenza.